Table 2 Univariate analysis of survival by clinicopathologic variables in patients with extrahepatic bile duct carcinoma
Factor | Characteristics | Number | Median survival (months) | P-value |
|---|---|---|---|---|
Sex | Male | 145 | 34 | 0.46 |
Female | 57 | 27 | ||
Sizea | 2.5b | 202 | 33c | 0.18 |
Growth pattern | Papillary | 25 | 53 | 0.001* |
Nodular | 17 | — | ||
Infiltrative | 160 | 29 | ||
T classification | T1 | 41 | — | <0.001* |
T2 | 65 | 29 | ||
T3 | 86 | 27 | ||
T4 | 10 | 13 | ||
Lymph node metastasis | Present | 65 | 18 | <0.001* |
Absent | 137 | 45 | ||
Hepatic invasion | Present | 11 | 18 | 0.23 |
Absent | 191 | 33 | ||
Pancreatic invasion | Present | 84 | 27 | 0.03* |
Absent | 118 | 41 | ||
Duodenal invasion | Present | 10 | 13 | 0.003* |
Absent | 192 | 35 | ||
Resection marginal status | Positive | 44 | 20 | 0.04* |
Negative | 158 | 38 | ||
Perineural invasion | Present | 137 | 29 | 0.07 |
Absent | 65 | 50 | ||
Vascular invasion | Present | 48 | 19 | 0.002* |
Absent | 154 | 42 | ||
KIT expression | Present | 49 | Not determined | 0.01* |
Absent | 153 | 30 |